OvercastNow
17 °C
63 °F
RainMon
19 °C
67 °F
Chance of a ThunderstormTue
12 °C
54 °F
OvercastWed
8 °C
47 °F
Send Us A News Tip

Tuesday March 6th, 2012

Posted at 2:30pm

Print Friendly, PDF & Email

The three local Windsor Hospitals have released this joint statement on shortages of injectable medications:

Windsor-Essex hospitals are closely monitoring inventories of injectable medications in the wake of a shortage of products from a Quebec manufacturer.

Windsor Regional Hospital, Hôtel-Dieu Grace Hospital and Leamington District Memorial Hospital continue to work closely with our purchasing agent, Medbuy Corp., to ensure adequate supplies of these medications are available. The hospitals have committed to resource sharing, under the Windsor-Essex Regional Pharmacy Service, in the event of significant supply impacts at any one site.

Hospitals throughout Canada are seeing their inventories impacted by the reduced production at Sandoz Canada’s manufacturing facility in Boucherville, Que. The plant produces the vast majority of sterile injectable medicines for hospitals nationwide – some 140 products are sole sourced through the Quebec plant.

Many of the pain medications received through Sandoz, including morphine, are used for post-operative patients. Further disruptions to these supplies could result in the cancellation of some pre-scheduled surgeries. While at this point there have been no such cancellations attributable to the drug shortage at Sandoz, there is some risk of cancellations in the near future should the supply situation not be corrected in a short timeframe.

We continue to monitor the situation closely, and we will be vigilant in protecting the supplies currently in stock to ensure those in most urgent need receive these medications. All three hospitals are committed to ensuring that any use of alternate medications will not affect the quality of care that patients receive, or the safety of that care.

While we remain cautiously optimistic that the shortage will be resolved, the three local hospitals will closely collaborate on our available resources in the best interests of patients.

We support the Health Canada and the Ontario Ministry of Health and Long-Term Care in their efforts to address this nationwide issue in a timely manner.

Do You Like This Article?